Meijer, L. L., Puik, J. R., Peters, G. J., Kazemier, G., & Giovannetti, E. (2016). hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients. Oncologist.
Chicago ZitierstilMeijer, Laura L., Jisce R. Puik, Godefridus J. Peters, Geert Kazemier, und Elisa Giovannetti. "HENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients." Oncologist 2016.
MLA ZitierstilMeijer, Laura L., et al. "HENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients." Oncologist 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.